Generated: December 18, 2017
DrugPatentWatch Database Preview
Details for New Drug Application (NDA): 206162
« Back to Dashboard
, which is a drug marketed by Astrazeneca Pharms and is included in two NDAs. It is available from one supplier. There are eight patents protecting this drug. Additional details are available on the LYNPARZA profile page.
The generic ingredient in LYNPARZA is olaparib. There is one drug master file entry for this compound. One supplier is listed for this compound. Additional details are available on the olaparib profile page.
Summary for 206162
Pharmacology for NDA: 206162
Suppliers and Packaging for NDA: 206162
||National Drug Code
||AstraZeneca Pharmaceuticals LP
||112 CAPSULE in 1 BOTTLE (0310-0657-58)
|Complete Access Available with Subscription
Summary for product number 001
|Approval Date:||Dec 19, 2014||TE:||RLD:||Yes|
|Regulatory Exclusivity Expiration:||Dec 19, 2019
|Regulatory Exclusivity Use:||NEW CHEMICAL ENTITY|
|Regulatory Exclusivity Expiration:||Dec 19, 2021
|Regulatory Exclusivity Use:||ORPHAN DRUG EXCLUSIVITY|
|Patent:||► Subscribe||Patent Expiration:||Apr 29, 2022||Product Flag?||Y||Substance Flag?||Y||Delist Request?|
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.